The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Cardiac risk factors and adverse events among patients receiving first-line CLL treatment in a real-world community practice setting.
 
Anthony R. Mato
Consulting or Advisory Role - Abbvie/Genentech; Acerta Pharma/AstraZeneca; Adaptive Biotechnologies; Bristol-Myers Squibb/Pfizer; Celgene; Curio/Vaniam Group; DTRM; Johnson & Johnson; Loxo/Lilly; Merck; Pharmacyclics; TG Therapeutics; Verastem
Research Funding - Abbvie/Genentech; Acerta Pharma/AstraZeneca; Adaptive Biotechnologies; DTRM; Genmab; Johnson & Johnson; LOXO; Nurix; Pharmacyclics; Regeneron; Sunesis Pharmaceuticals; TG Therapeutics
 
Boxiong Tang
Employment - BeiGene
Stock and Other Ownership Interests - BeiGene
 
Soraya Azmi
Employment - BeiGene
Stock and Other Ownership Interests - BeiGene
Research Funding - BeiGene
 
Keri Yang
Employment - BeiGene
Stock and Other Ownership Interests - BeiGene
 
Nicola Wallis
Employment - BeiGene
Stock and Other Ownership Interests - BeiGene
 
Jennifer C Stern
Employment - BeiGene
Stock and Other Ownership Interests - BeiGene
 
Eric Hedrick
Employment - BeiGene
Leadership - BeiGene
Stock and Other Ownership Interests - BeiGene
 
Jane Huang
Employment - BeiGene
Leadership - BeiGene
Stock and Other Ownership Interests - BeiGene
Patents, Royalties, Other Intellectual Property - BeiGene
Travel, Accommodations, Expenses - BeiGene
 
Jeff Porter Sharman
Employment - US Oncology Network
Stock and Other Ownership Interests - VelosBio
Consulting or Advisory Role - Abbvie; Acerta Pharma/AstraZeneca; Beigene; Bristol-Myers Squibb; Celgene; Genentech; Pfizer; Pharmacyclics; TG Therapeutics
Research Funding - Acerta Pharma (Inst); Celgene (Inst); Genentech (Inst); Gilead Sciences (Inst); Merck (Inst); Pharmacyclics (Inst); Seagen (Inst); Takeda (Inst); TG Therapeutics (Inst)